Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Etoposide in Relapsed Non-Hodgkin's Lymphoma
NCT00002880Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Nov 1996
- Primary completion
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etoposide phosphate in non-Hodgkin lymphoma (NHL), sponsored by Cancer and Leukemia Group B. Started Nov 1996; status: completed.
02
Drugs
etoposide phosphate
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00002880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002880.